Skip to main content

Multiple modalities in Pharma manufacturing

Pharma industry manufacturers are considering how advanced therapy medicinal products (ATMPs) and other traditional modalities can be combined within the same facility or within a newly constructed agnostic building.

PM Group’s Tom Bannon, Advanced Therapies SME, and Alf Penfold, Regulatory SME, address these and other questions related to multi-modality manufacturing.

To read more, follow the link below.